Related references
Note: Only part of the references are listed.The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
Hanny Al-Samkari et al.
HAEMATOLOGICA (2018)
The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
Hanny Al-Samkari et al.
HAEMATOLOGICA (2018)
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Charles A. Schiffer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
Ann Janssens et al.
ANNALS OF HEMATOLOGY (2016)
Platelet Transfusion: A Clinical Practice Guideline From the AABB
Richard M. Kaufman et al.
ANNALS OF INTERNAL MEDICINE (2015)
Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period
R. Ramakrishna et al.
INTERNAL MEDICINE JOURNAL (2015)
Romiplostim in the management of the thrombocytopenic surgical patient
Ariela L. Marshall et al.
TRANSFUSION (2015)
Preoperative Thrombocytopenia and Postoperative Outcomes after Noncardiac Surgery
Laurent G. Glance et al.
ANESTHESIOLOGY (2014)
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Ronan Desmond et al.
BLOOD (2014)
Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and Thrombocytopenia
Aristoteles Giagounidis et al.
CANCER (2014)
Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy
Nezam H. Afdhal et al.
GASTROENTEROLOGY (2014)
Romiplostim for management of chemotherapy-induced thrombocytopenia
R. Parameswaran et al.
SUPPORTIVE CARE IN CANCER (2014)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The biology of thrombopoietin and thrombopoietin receptor agonists
David J. Kuter
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis
Mohamed M. Moussa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
SINGLE USE OF ROMIPLOSTIM THROMBOPOIETIN ANALOGUE IN SEVERE THROMBOCYTOPENIA FOR OUTPATIENT PERCUTANEOUS LIVER BIOPSY IN PATIENTS WITH CHRONIC LIVER DISEASE-A RANDOMIZED DOUBLE BLINDED PROSPECTIVE TRIAL
P. P. Basu et al.
JOURNAL OF HEPATOLOGY (2012)
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Nezam H. Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Subcutaneous or Intravenous Administration of Romiplostim in Thrombocytopenic Patients With Lower Risk Myelodysplastic Syndromes
Mikkael A. Sekeres et al.
CANCER (2011)
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy
Hagop M. Kantarjian et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
David J. Kuter et al.
BLOOD (2009)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
